Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and Full Year 2024 Earnings Call. At this time, all lines are in ...

We came across a bullish thesis on Atea Pharmaceuticals, Inc. (AVIR) on Substack by Turtles Research. In this article, we ...

Investment analysts at HC Wainwright cut their FY2028 earnings estimates for shares of Milestone Pharmaceuticals in a report issued on Monday, March 17th. HC Wainwright analyst P. Trucchio now expects ...

Sales began increasing once supply levels resumed, and we are hopeful that sales of Renacidin will return to their previous ...

The the Court of Justice for the European Union reports a decrease in new IP cases in 2024 despite a 12% increase in overall ...

Many seek natural solutions to maintain balanced blood sugar levels in today’s health-conscious world. Among these natural ...

Milestone Pharmaceuticals faces a pivotal FDA PDUFA decision for etripamil in PSVT. Read here for a detailed investment ...

Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

American pharmaceutical giant Johnson & Johnson (JNJ) is boosting its U.S. investments by 25% to more than $55 billion over ...

Ultimately, Chimerix’s board went with Jazz’s offer due to its cash payable nature and the recent downward trend in biopharma ...

Another double-digit seed has advanced in the NCAA men's tournament. No. 12 Colorado State knocked off Memphis in their first ...